Search: Analyst Coverage

Here are analysts’ favorite marijuana stocks, which they expect to rise as much as 82% in the next year

Marijuana stocks have surged this year as investors anticipate wider acceptance of legal distribution of recreational products in the U.S. Your best way to ride this wave may be through exchange traded funds. Recent coverage includes efforts by Senate Majority Leader Chuck Schumer to introduce legislation for the federal legalization of marijuana and New York Gov. Andrew Cuomo’s drive toward…

Aurora Cannabis Analyst Says Stock Will Go Up In Smoke, Sets Zero Price Target

Aurora Cannabis Inc (NYSE: ACB) shares were burning up Monday after a sell-side analyst took the most bearish stance possible on the Canadian company’s stock. GLJ Research analyst Gordon Johnson initiated coverage of Aurora Cannabis with a Sell rating and zero price target. Aurora Cannabis’ equity is effectively worthless, Johnson said in the Monday initiation note. READ MORE: https://finance.yahoo.com/news/aurora-cannabis-analyst-says-stock-213011564.html?.tsrc=rss

‘We are calling the bottom’: Analyst sees brighter outlook for pot stocks

A New York-based analyst says Canada’s cannabis sector has bottomed out, predicting several positive events in the coming year should catalyze pot stocks as valuations trade at two-year lows. Cantor Fitzgerald Analyst Pablo Zuanic, who initiated coverage of six cannabis stocks Monday, said in a report to clients that several pot companies are attractive at current levels based on the…

Aurora Cannabis stock slides premarket as Piper initiates coverage with neutral rating

Piper Jaffray initiated coverage of a range of cannabis stocks on Tuesday, assigning overweight ratings, the equivalent of buy, to Cresco Labs Inc. , Charlotte’s Web Holdings Inc. , CV Sciences Inc. , Cronos Group Inc. and Green Thumb Industries Inc. , but rating Aurora Cannabis Inc. as neutral. “Aurora has a premium valuation relative to peers but less visibility…